 CAMBRIDGE, Mass.--BUSINESS WIRE--InVivo Therapeutics Holdings Corp. Nasdaq: NVIV, a research and clinical-stage biomaterials and biotechnology company with a focus on the treatment of spinal cord injuries, today reminded stockholders that their virtual Annual Meeting of Stockholders is scheduled for Friday, July 16, 2021 at 11 a.m., ET and called on stockholders to vote to ensure that a quorum is present to hold the meeting and that the Companys proxy proposals are passed. Stockholders hol 